Table 1.
Demographic information for all treatment groups observed in this study.
| Treatment Group | Oligometastatic Definitive CRT (n = 19) | Oligometastatic Palliative Tx (n = 17) |
Widely Metastatic (Any Tx, n = 42) |
|---|---|---|---|
| Median age at diagnosis (Years) | 65 | 69 | 60 |
| Age range | 30–81 | 52–93 | 26–81 |
| Male | 18 (94.7%) | 6 (35.3%) | 37 (88.1%) |
| Female | 1 (5.3%) | 11 (64.7%) | 5 (11.9%) |
| Adenocarcinoma | 17 (89.5%) | 10 (58.8%) | 35 (83.3%) |
| Squamous Cell Carcinoma | 2 (10.5%) | 7 (41.2%) | 7 (16.7%) |
| Diagnosed prior to 2013 | 5 (26.3%) | 7 (41.2%) | 10 (23.8%) |
| Diagnosed in 2013 or after | 14 (73.7%) | 10 (58.8%) | 32 (76.2%) |
| Average ECOG Status (0–4) | 0.42 (0–1) | 1.41 (0–3) | 1.04 (0–3) |
| Median OS (months) | 90.2 | 8.1 | 11.7 |
Abbreviations: CRT = chemoradiation; Tx = treatment; OS = overall survival.